With a market cap of has a large market cap size. Biogen Inc. (NASDAQ: BIIB) has been on the stock market since its IPO date on the 9/17/1991. Biogen Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Biogen Inc., is 1818.74, and so far today it has a volume of 724788. Performance year to date since the 9/17/1991 is -15.19%.
To help you determine whether Biogen Inc. is undervalued the following values will help you decide. P/E is 15.96 and forward P/E is 12.95. PEG perhaps more useful shows that Biogen Inc. has a value for PEG of 2.04. P/S ratio is 5.2 and the P/B ratio is 5.51. The P/Cash and P/Free cash flow is 15.86 and 17.37 respectively.
At the current price Biogen Inc. is trading at, 262.02 (0.85% today), Biogen Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 16.28, and this is looking to grow in the next year to 6.03% after growing 24.00% this past year. EPS growth quarter over quarter is 26.80%, and 6.70% for sales growth quarter over quarter.
The number of shares outstanding is 218.9, and the number of shares float is 218.43. The senior management bring insider ownership to 0.10%, and institutional ownership is at 88.60%. The float short is 1.14%, with the short ratio at a value of 1.37. Management has seen a return on assets of 19.00%, and also a return on investment of 23.50%.
The ability for Biogen Inc., to deal with debt, means it current ratio is 2.6, and quick ratio is 2.2. Long term debt/equity is 0.63 and total debt/equity is 0.63. In terms of margins, Biogen Inc. has a gross margin of 88.70%, with its operating margin at 47.10%, and Biogen Inc. has a profit margin of 33.80%.
The 52 week high is -36.44%, with 17.49% being its 52 week low. The 20 day simple moving average is 2.19% and the 200 day simple moving average is -3.15%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.